Home/Filings/4/0000899243-20-030316
4//SEC Filing

Invus Public Equities, L.P. 4

Accession 0000899243-20-030316

CIK 0001604477other

Filed

Nov 2, 7:00 PM ET

Accepted

Nov 3, 8:00 PM ET

Size

26.2 KB

Accession

0000899243-20-030316

Insider Transaction Report

Form 4
Period: 2020-11-03
Transactions
  • Conversion

    Series D Convertible Preferred Stock

    2020-11-03240,3750 total
    Common Stock (253,114 underlying)
  • Conversion

    Series C Convertible Preferred Stock

    2020-11-03843,4900 total
    Common Stock (888,194 underlying)
  • Conversion

    Common Stock

    2020-11-03+1,141,3081,141,308 total
  • Purchase

    Common Stock

    2020-11-03$16.00/sh+465,000$7,440,0001,606,308 total
Transactions
  • Conversion

    Common Stock

    2020-11-03+1,141,3081,141,308 total
  • Conversion

    Series D Convertible Preferred Stock

    2020-11-03240,3750 total
    Common Stock (253,114 underlying)
  • Purchase

    Common Stock

    2020-11-03$16.00/sh+465,000$7,440,0001,606,308 total
  • Conversion

    Series C Convertible Preferred Stock

    2020-11-03843,4900 total
    Common Stock (888,194 underlying)
Transactions
  • Purchase

    Common Stock

    2020-11-03$16.00/sh+465,000$7,440,0001,606,308 total
  • Conversion

    Common Stock

    2020-11-03+1,141,3081,141,308 total
  • Conversion

    Series D Convertible Preferred Stock

    2020-11-03240,3750 total
    Common Stock (253,114 underlying)
  • Conversion

    Series C Convertible Preferred Stock

    2020-11-03843,4900 total
    Common Stock (888,194 underlying)
Minne Pascal
10% Owner
Transactions
  • Purchase

    Common Stock

    2020-11-03$16.00/sh+465,000$7,440,0001,606,308 total
  • Conversion

    Series C Convertible Preferred Stock

    2020-11-03843,4900 total
    Common Stock (888,194 underlying)
  • Conversion

    Common Stock

    2020-11-03+1,141,3081,141,308 total
  • Conversion

    Series D Convertible Preferred Stock

    2020-11-03240,3750 total
    Common Stock (253,114 underlying)
Transactions
  • Conversion

    Series D Convertible Preferred Stock

    2020-11-03240,3750 total
    Common Stock (253,114 underlying)
  • Purchase

    Common Stock

    2020-11-03$16.00/sh+465,000$7,440,0001,606,308 total
  • Conversion

    Common Stock

    2020-11-03+1,141,3081,141,308 total
  • Conversion

    Series C Convertible Preferred Stock

    2020-11-03843,4900 total
    Common Stock (888,194 underlying)
WESTEND SA
10% Owner
Transactions
  • Conversion

    Common Stock

    2020-11-03+1,141,3081,141,308 total
  • Purchase

    Common Stock

    2020-11-03$16.00/sh+465,000$7,440,0001,606,308 total
  • Conversion

    Series D Convertible Preferred Stock

    2020-11-03240,3750 total
    Common Stock (253,114 underlying)
  • Conversion

    Series C Convertible Preferred Stock

    2020-11-03843,4900 total
    Common Stock (888,194 underlying)
Transactions
  • Purchase

    Common Stock

    2020-11-03$16.00/sh+465,000$7,440,0001,606,308 total
  • Conversion

    Series C Convertible Preferred Stock

    2020-11-03843,4900 total
    Common Stock (888,194 underlying)
  • Conversion

    Series D Convertible Preferred Stock

    2020-11-03240,3750 total
    Common Stock (253,114 underlying)
  • Conversion

    Common Stock

    2020-11-03+1,141,3081,141,308 total
Transactions
  • Conversion

    Common Stock

    2020-11-03+1,141,3081,141,308 total
  • Purchase

    Common Stock

    2020-11-03$16.00/sh+465,000$7,440,0001,606,308 total
  • Conversion

    Series D Convertible Preferred Stock

    2020-11-03240,3750 total
    Common Stock (253,114 underlying)
  • Conversion

    Series C Convertible Preferred Stock

    2020-11-03843,4900 total
    Common Stock (888,194 underlying)
Transactions
  • Conversion

    Common Stock

    2020-11-03+1,141,3081,141,308 total
  • Conversion

    Series C Convertible Preferred Stock

    2020-11-03843,4900 total
    Common Stock (888,194 underlying)
  • Purchase

    Common Stock

    2020-11-03$16.00/sh+465,000$7,440,0001,606,308 total
  • Conversion

    Series D Convertible Preferred Stock

    2020-11-03240,3750 total
    Common Stock (253,114 underlying)
Footnotes (3)
  • [F1]On November 3, 2020, the Series C Convertible Preferred Stock and the Series D Convertible Preferred Stock each converted to Common Stock on a 1.0530 for 1 basis without payment of further consideration upon the closing of the Issuer's initial public offering. The shares had no expiration date.
  • [F2]The shares are held directly by Invus Public Equities, L.P. The general partner of Invus Public Equities, L.P. is Invus Public Equities Advisors, LLC. Artal Treasury Ltd is the managing member of Invus Public Equities Advisors, LLC. Artal Treasury Ltd is a wholly owned subsidiary of the Geneva branch of Artal International S.C.A. The managing partner of Artal International S.C.A. is Artal International Management S.A., which is a wholly owned subsidiary of Artal Group S.A. Westend S.A. is the parent company of Artal Group S.A., and the majority stockholder of Westend S.A. is Stichting Administratiekantoor Westend ("Stichting").
  • [F3](Continued from Footnote 2) Mr. Pascal Minne is the sole member of the board of Stichting. Each of the Reporting Persons, other than Invus Public Equities L.P., disclaims beneficial ownership of the securities held by the other Reporting Persons, except to the extent of such Reporting Person's pecuniary interest therein, and, pursuant to Rule 16a-1(a)(4) under the Exchange Act, each of the Reporting Persons (other than to the extent it directly holds securities reported herein) states that the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 of the Exchange Act or for any other purpose.

Issuer

SQZ Biotechnologies Co

CIK 0001604477

Entity typeother

Related Parties

1
  • filerCIK 0001340097

Filing Metadata

Form type
4
Filed
Nov 2, 7:00 PM ET
Accepted
Nov 3, 8:00 PM ET
Size
26.2 KB